TARA — Protara Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Protara Therapeutics Announces Appointment Of Patrick Fabbio As CFO
Protara Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Protara Therapeutics Inc Reports Q3 Loss Per Share Of $0.68
Protara Therapeutics Inc expected to post a loss of 76 cents a share - Earnings Preview
Brief: Protara Therapeutics Posts Q2 Loss Per Share $0.80
Brief: Protara Therapeutics Announces Departure Of Chief Financial Officer
Brief: Protara Therapeutics Announces Trials In Progress Poster Presentation For Advanced-1 Trial In Nmibc At 2022 American Society Of Clinical Oncology Annual Meeting
Brief: Protara Therapeutics Presents Results From Analysis Of Studies Of OK-432 In Patients With Lymphatic Malformations
Protara Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Protara Therapeutics Q1 Loss Per Share $0.96
Protara Therapeutics Inc expected to post a loss of 90 cents a share - Earnings Preview
Protara rises on dosing patient in bladder cancer drug study
Brief: Protara Therapeutics Doses First Patient In Advanced-1 Phase 1 Study Of TARA-002 In Non-Muscle Invasive Bladder Cancer
Protara Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Protara Therapeutics Reports Q4 Loss Of 91 Cents Per Share
Protara Therapeutics Inc expected to post a loss of 94 cents a share - Earnings Preview
Brief: Protara Therapeutics Q3 Loss Per Share Of $0.96
U.S. STOCKS ON THE MOVE-Nike, CureVac, Quanterix, Signet Jewelers
-Лидеры и аутсайдеры Уолл-cтрит: ESS Inc, OneSmart, FREYR Battery SA